These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16183034)

  • 21. Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis.
    Spach KM; Pedersen LB; Nashold FE; Kayo T; Yandell BS; Prolla TA; Hayes CE
    Physiol Genomics; 2004 Jul; 18(2):141-51. PubMed ID: 15138306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
    Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
    Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parathyroid hormone modulation of 25-hydroxyvitamin D3 metabolism by cultured chick kidney cells is mimicked and enhanced by forskolin.
    Henry HL
    Endocrinology; 1985 Feb; 116(2):503-10. PubMed ID: 2981664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D.
    Horwitz MJ; Tedesco MB; Sereika SM; Syed MA; Garcia-Ocaña A; Bisello A; Hollis BW; Rosen CJ; Wysolmerski JJ; Dann P; Gundberg C; Stewart AF
    J Bone Miner Res; 2005 Oct; 20(10):1792-803. PubMed ID: 16160737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of dietary calcium in the physiology of vitamin D toxicity: excess dietary vitamin D3 blunts parathyroid hormone induction of kidney 1-hydroxylase.
    Beckman MJ; Johnson JA; Goff JP; Reinhardt TA; Beitz DC; Horst RL
    Arch Biochem Biophys; 1995 Jun; 319(2):535-9. PubMed ID: 7786039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of 25-hydroxyvitamin D3-1alpha-hydroxylase in normal and malignant breast tissue.
    Friedrich M; Diesing D; Cordes T; Fischer D; Becker S; Chen TC; Flanagan JN; Tangpricha V; Gherson I; Holick MF; Reichrath J
    Anticancer Res; 2006; 26(4A):2615-20. PubMed ID: 16886671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic models show that parathyroid hormone and 1,25-dihydroxyvitamin D3 play distinct and synergistic roles in postnatal mineral ion homeostasis and skeletal development.
    Xue Y; Karaplis AC; Hendy GN; Goltzman D; Miao D
    Hum Mol Genet; 2005 Jun; 14(11):1515-28. PubMed ID: 15843402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of the X-linked Hyp mutation and vitamin D status on induction of renal 25-hydroxyvitamin D3-24-hydroxylase.
    Tenenhouse HS; Jones G
    Endocrinology; 1987 Feb; 120(2):609-16. PubMed ID: 3803293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Ifng gene is essential for Vdr gene expression and vitamin D₃-mediated reduction of the pathogenic T cell burden in the central nervous system in experimental autoimmune encephalomyelitis, a multiple sclerosis model.
    Spanier JA; Nashold FE; Olson JK; Hayes CE
    J Immunol; 2012 Sep; 189(6):3188-97. PubMed ID: 22896638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of experimental autoimmune encephalomyelitis (EAE) in mice requires vitamin D and the vitamin D receptor.
    Wang Y; Marling SJ; Zhu JG; Severson KS; DeLuca HF
    Proc Natl Acad Sci U S A; 2012 May; 109(22):8501-4. PubMed ID: 22592802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted disruption of the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in ras-transformed keratinocytes demonstrates that locally produced 1alpha,25-dihydroxyvitamin D3 suppresses growth and induces differentiation in an autocrine fashion.
    Huang DC; Papavasiliou V; Rhim JS; Horst RL; Kremer R
    Mol Cancer Res; 2002 Nov; 1(1):56-67. PubMed ID: 12496369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of messenger ribonucleic acid expression of 1 alpha,25-dihydroxyvitamin D3-24-hydroxylase in rat osteoblasts.
    Nishimura A; Shinki T; Jin CH; Ohyama Y; Noshiro M; Okuda K; Suda T
    Endocrinology; 1994 Apr; 134(4):1794-9. PubMed ID: 8137744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the Administration of 25(OH) Vitamin D3 in an Experimental Model of Chronic Kidney Disease in Animals Null for 1-Alpha-Hydroxylase.
    Torremadé N; Bozic M; Goltzman D; Fernandez E; Valdivielso JM
    PLoS One; 2017; 12(1):e0170654. PubMed ID: 28107527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin D metabolism in pregnant rabbits: differences between the maternal and fetal response to administration of large amounts of vitamin D3.
    Kubota M; Ohno J; Shiina Y; Suda T
    Endocrinology; 1982 Jun; 110(6):1950-6. PubMed ID: 6280980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted ablation of the 25-hydroxyvitamin D 1alpha -hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction.
    Panda DK; Miao D; Tremblay ML; Sirois J; Farookhi R; Hendy GN; Goltzman D
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7498-503. PubMed ID: 11416220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced 1alpha-hydroxylase activity in human prostate cancer cells correlates with decreased susceptibility to 25-hydroxyvitamin D3-induced growth inhibition.
    Hsu JY; Feldman D; McNeal JE; Peehl DM
    Cancer Res; 2001 Apr; 61(7):2852-6. PubMed ID: 11306457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1Alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxyvitamin D3, is a potent suppressor of parathyroid hormone secretion.
    Brown AJ; Ritter C; Slatopolsky E; Muralidharan KR; Okamura WH; Reddy GS
    J Cell Biochem; 1999 Apr; 73(1):106-13. PubMed ID: 10088729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of parathyroid hormone on the renal 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 production of young and adult rats.
    Armbrecht HJ; Wongsurawat N; Zenser TV; Davis BB
    Endocrinology; 1982 Oct; 111(4):1339-44. PubMed ID: 6981502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis.
    Cantorna MT; Hayes CE; DeLuca HF
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7861-4. PubMed ID: 8755567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1,25-Dihydroxy-24-OXO-16ene-vitamin D3, a renal metabolite of the vitamin D analog 1,25-dihydroxy-16ene-vitamin D3, exerts immunosuppressive activity equal to its parent without causing hypercalcemia in vivo.
    Lemire JM; Archer DC; Reddy GS
    Endocrinology; 1994 Dec; 135(6):2818-21. PubMed ID: 7988477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.